Research suggests that ivy leaf has been explored in the context of respiratory inflammation, though the single available study in this collection does not directly examine ivy leaf as a standalone intervention — rather, it investigates bradykinin-driven inflammatory pathways in pharyngitis using human respiratory cell and three-dimensional tissue models, testing various treatments including a proprietary combination formula. Studies of this type, conducted entirely in laboratory and tissue model settings, can offer mechanistic insights but cannot establish clinical effectiveness in human patients. A significant limitation of the available evidence here is that the sole study was fully funded by the manufacturer of the product being tested, with all authors listed as company employees, which introduces a substantial risk of bias. Overall, the current evidence base is too narrow and methodologically constrained to draw meaningful conclusions about ivy leaf's role in respiratory health.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| A novel anti-inflammatory treatment for bradykinin-induced sore throat or pha... | Other | 2020 | — | 85 |